Neutrophils, the largest innate immune cell population in humans, are the primary proinflammatory sentinel in the ischemia-reperfusion injury (IRI) mechanism in orthotopic liver transplantation (OLT). Carcinoembryonic antigen–related cell adhesion molecule 1 (CEACAM1, CC1, or CD66a) is essential in neutrophil activation and serves as a checkpoint regulator of innate immune-driven IRI cascade in OLT. Although CC1 alternative splicing generates two functionally distinct short and long cytoplasmic isoforms, their role in neutrophil activation remains unknown. Here, we undertook molecular and functional studies to interrogate the significance of neutrophil CC1 signaling in mouse and human OLT recipients. In the experimental arm, we employed a mouse OLT model to document that ablation of recipient-derived neutrophil CC1-long (CC1-L) isotype aggravated hepatic IRI by promoting neutrophil extracellular traps (NETs). Notably, by regulating the S1P–S1PR2/S1PR3 axis, neutrophil CC1-L determined susceptibility to NET formation via autophagy signaling. In the clinical arm, liver grafts from 55 transplant patients selectively enriched for neutrophil CC1-L showed relative resistance to ischemia-reperfusion (IR) stress/tissue damage, improved hepatocellular function, and clinical outcomes. In conclusion, despite neutrophils being considered a principal villain in peritransplant tissue injury, their CC1-L isoform may serve as a regulator of IR stress resistance/NETosis in human and mouse OLT recipients.
Hirofumi Hirao, Hidenobu Kojima, Kenneth J. Dery, Kojiro Nakamura, Kentaro Kadono, Yuan Zhai, Douglas G. Farmer, Fady M. Kaldas, Jerzy W. Kupiec-Weglinski
Title and authors | Publication | Year |
---|---|---|
Genome-wide KAS-Seq mapping of leukocytes in ischemia-reperfusion model reveals IL7R as a potential therapeutic target for ischemia-reperfusion injury
Zhang L, Duolikun M, Chen H, Wang Z, Li X, Xiao H, Dong Y, Chen H, Liu F, Fan S, Lin J, Chen L |
Scientific Reports | 2025 |
Reversal of cholestatic liver disease by the inhibition of sphingosine 1-phosphate receptor 2 signaling
Cao H, Chen L, Zeng Z, Wu X, Lei Y, Jia W, Yue G, Yi B, Li YJ, Shi Y |
PeerJ | 2024 |
Suppression of ferroptosis via USP19-mediated deubiquitination of SLC7A11 in ischemia-free liver transplantation
Jinghong Xu, Shirui Chen, Di Liu, Qi Zhang, Tao Luo, Jiaxing Zhu, Liang Zhou, Yuan Lin, Hongyu Pan, Yichao Chen, Qiang Zhao, Tielong Wang, Schlegel Andrea, Björn Nashan, Stefan G. Tullius, Changjie Cai, Jun Cui, Xiaoshun He, Zhiyong Guo |
Advanced science (Weinheim, Baden-Wurttemberg, Germany) | 2024 |
Bile acids attenuate hepatic inflammation during ischemia/reperfusion injury
Huang K, Wang C, Mei B, Li J, Ren T, Zhan H, Zhang Y, Zhang B, Lv X, Zhang Q, Guan Y, Zhang X, Wang G, Pan W, Xu P, Wang H, Zhang J |
2024 | |
Targeting NETosis: nature's alarm system in cancer progression.
Liang Y, Wu G, Tan J, Xiao X, Yang L, Saw PE |
Cancer drug resistance (Alhambra, Calif.) | 2024 |
Inhibition of CEACAM1 expression in cytokine-activated neutrophils using JAK inhibitors
Matsumoto H, Sudo R, Fujita Y, Onizawa M, Saito K, Sumichika Y, Yoshida S, Temmoku J, Matsuoka N, Asano T, Sato S, Suzuki E, Machida T, Migita K |
BMC Immunology | 2024 |
CEACAM1 increased the lymphangiogenesis through miR-423-5p and NF- kB in Non-Small Cell Lung Cancer
Yu J, Cai W, Zhou T, Men B, Chen S, Tu D, Guo W, Wang J, Zhao F, Wang Y |
Biochemistry and Biophysics Reports | 2024 |
Current status and perspective on molecular targets and therapeutic intervention strategy in hepatic ischemia-reperfusion injury.
Liu J, Luo R, Zhang Y, Li X |
Clinical and molecular hepatology | 2024 |
Mechanism and function of CEACAM1 splice isoforms
Dery KJ, Najjar SM, Beauchemin N, Shively JE, Kupiec\u2010Weglinski JW |
European Journal of Clinical Investigation | 2024 |
The role of CEACAMs in neutrophil function
Skubitz KM |
European Journal of Clinical Investigation | 2024 |
Hepatic GDP-fucose transporter SLC35C1 attenuates cholestatic liver injury and inflammation by inducing CEACAM1 N153 fucosylation
Zhang L, Xie P, Li M, Zhang X, Fei S, Zhao N, Li L, Xie Q, Xu Z, Tang W, Zhu G, Zhu Z, Xu Z, Li J, Zhang C, Boyer JL, Chen W, Cai SY, Pan Q, Chai J |
Hepatology (Baltimore, Md.) | 2024 |
Current Investigation of Carcinoembryonic Antigen Cell Adhesion Molecule (CEACAM) Biology Summary of the 32nd CEA Symposium: 20–23 September 2024. Würzburg, Germany
Fleckenstein JM, Najjar SM, Zimmermann W, Hauck CR, Nguyen Q, Mejias-Luque R, Bhattacharyya A, McCarthy AJ, Sarkar A, Kujawski M, Konieva A, Elyateem F, Kube-Golovin I, Wennemuth G, Kammerer R, Skubitz KM, Shively JE, Dery KJ, Dveksler G, Götz L, Kleefeldt F, Ergün S |
European journal of clinical investigation | 2024 |
Alternative splicing of CEACAM1 orchestrated by hypoxia-inducible factor–1α enhances hepatic ischemia tolerance
Kenneth Dery, Hidenobu Kojima, Kentaro Kadono, Hirofumi Hirao, Brian Cheng, Yuan Zhai, xiaoyi Yuan, Holger K. Eltzschig, Jerzy W. Kupiec-Weglinski |
Science Translational Medicine | 2023 |
Avoid being trapped by your liver: Ischemia-reperfusion injury in liver transplant triggers SP1-mediated NETosis
Andrew Gelman |
Journal of Clinical Investigation | 2023 |
Updates on the Immune Cell Basis of Hepatic Ischemia-Reperfusion Injury.
Heo MJ, Suh JH, Poulsen KL, Ju C, Kim KH |
Molecules and Cells | 2023 |
New therapeutic concepts against ischemia-reperfusion injury in organ transplantation
Dery KJ, Yao S, Cheng B, Kupiec-Weglinski JW |
Expert Review of Clinical Immunology | 2023 |
JTE-013 Alleviates Pulmonary Fibrosis by Affecting the RhoA/YAP Pathway and Mitochondrial Fusion/Fission
Zhou J, Song Y, Wang X, Li X, Liu C, Tian C, Wang C, Li L, Yan G, Cui H |
Pharmaceuticals | 2023 |
Reduced Ceramides Are Associated with Acute Rejection in Liver Transplant Patients and Skin Graft and Hepatocyte Transplant Mice, Reducing Tolerogenic Dendritic Cells
Yoo HJ, Yi Y, Kang Y, Kim SJ, Yoon YI, Tran PH, Kang T, Kim MK, Han J, Tak E, Ahn CS, Song GW, Park GC, Lee SG, Kim JJ, Jung DH, Hwang S, Kim N |
Molecules and Cells | 2023 |